Detailed price information for Integrated Biopharma Inc (INBP) from The Globe and Mail including charting and trades.

HILLSIDE, NJ / ACCESSWIRE / August 1, 2018 / Integrated BioPharma, Inc. (INBP) (the "Company" or "INBP") announced today the conversion of its Amended and Restated Convertible Secured Promissory Note, ...

HILLSIDE, NJ / ACCESSWIRE / April 8, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announces the launch of an updated investors website. "As part of our efforts in ...

Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, ...

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the ...

Integrated BioPharma Inc. Annual cash flow by MarketWatch. View INBP net cash flow, operating cash flow, operating expenses and cash dividends.

Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.